Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT04795895
Other study ID # 201907167RINB
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date March 1, 2021
Est. completion date October 2023

Study information

Verified date May 2023
Source National Taiwan University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Introduction: Data using ultrasonography to confirm correct position of the gastric tube is heterogeneous in approach sites, combination exams, and methodology. Aim: Find the best strategy to confirm gastric tube placement to avoid immediate complication. Method: A randomized controlled trial was initiated to compare ultrasonography and standard routine method, using non-inferiority design. The study will be conducted in one medical ICU with 59 beds at a medical center. The primary outcome is the correct rate as comparing with the chest radiography in each group. Total 190 patients is needed with estimated 10% drop-out rate.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 190
Est. completion date October 2023
Est. primary completion date October 2023
Accepts healthy volunteers No
Gender All
Age group 20 Years and older
Eligibility Inclusion Criteria: - Clinical indication of nasogastric tube placement - Age than 20 years old. Exclusion criteria: - Facial trauma or head-base fractures - Esophageal or gastric resection - Esophageal strictures or alkaline injury - Open wound in the area to prevent ultrasonography

Study Design


Related Conditions & MeSH terms

  • Critical Illness
  • Ultrasound for Confirmation of Gastric Tube Placement in Critically Ill Patients Under Invasive Mechanical Ventilation

Intervention

Diagnostic Test:
ultrasonography (US)
US evaluation was performed after insertion of the tube via subxiphoid approach for tube passing esophagogastric (EG) junction. The tube insertion procedure will be repeated no more than three attempts if no visualization by US.
Standard routine (SR)
Standard routine (SR)

Locations

Country Name City State
Taiwan National Taiwan University Hospital Taipei Test2

Sponsors (1)

Lead Sponsor Collaborator
National Taiwan University Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Primary correct rate as comparing with the chest radiography in each group 1 day
Secondary procedure time, tube placement confirmation time other than chest radiography method, and additional auscultation method in US group 1 day